Effective March 1, 2016, Option Care Enterprises, Inc. will be a preferred provider of intravenous and subcutaneous immunoglobulin (IVIG/SCIG) drugs provided in the home* for members covered by AmeriHealth New Jersey.
As one of the nation’s largest providers of home and alternate treatment site infusion services, Option Care’s specially trained nurses and pharmacists provide high-quality, high-touch clinical support to patients treated for complex conditions, including those receiving IG. Option Care IG patients report very high levels of satisfaction — 98 percent — with Option Care’s in-home visits and ongoing support calls to help them manage their conditions.[*]Option Care Enterprises, Inc. Data on file 2016.
IG therapy is prescribed to patients with immune system-related conditions, including primary immunodeficiency disorders (the body’s immune system doesn’t function properly), autoimmune disorders (the body attacks itself) and other conditions that benefit from the treatment. IG therapy is delivered one of two ways: IVIG is infused through a vein, and SCIG is delivered into the fatty tissue just below the skin. Including IVIG and SCIG, Option Care manages more than 55,000 IG infusions each year.[*]Orange J, Kirkham H, Ayer G, et al. Improved clinical outcomes for patients receiving immunoglobulin therapy through specialty pharmacy or home infusion services. Paper presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2015 Annual Scientific Meeting: Nov 5-9, 2015; San Antonio.
Home Infusion IG Therapy in Focus
在最近一项创新研究中，与大型国家数据库中记录的在其他环境中接受 IG 治疗的患者相比，接受了高水平临床监督的 Option Care 家庭 IG 患者拥有更好的疗效。
Option Care 可提供所有 IG 产品，公司 1,700 多位临床医师（包括经过 IVIG/SCIG 专门培训的护士和药剂师）提供高品质的护理，包括个性化的患者护理计划、临床监测每次输液，以及全面的患者和照料者教育。
*Members 可继续接受当前隶属于参与 AmeriHealth 新泽西提供者网络的医院或健康系统之家庭输液供应商的 IVIG/SCIG。